Literature DB >> 21924486

Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis.

Mohammad H Forouzanfar1, Kyle J Foreman, Allyne M Delossantos, Rafael Lozano, Alan D Lopez, Christopher J L Murray, Mohsen Naghavi.   

Abstract

BACKGROUND: Breast and cervical cancer are important causes of mortality in women aged ≥15 years. We undertook annual age-specific assessments of breast and cervical cancer in 187 countries.
METHODS: We systematically collected cancer registry data on mortality and incidence, vital registration, and verbal autopsy data for the period 1980-2010. We modelled the mortality-to-incidence (MI) ratio using a hierarchical model. Vital registration and verbal autopsy were supplemented with incidence multiplied by the MI ratio to yield a comprehensive database of mortality rates. We used Gaussian process regression to develop estimates of mortality with uncertainty by age, sex, country, and year. We used out-of-sample predictive validity to select the final model. Estimates of incidence with uncertainty were also generated with mortality and MI ratios.
FINDINGS: Global breast cancer incidence increased from 641,000 (95% uncertainty intervals 610,000-750,000) cases in 1980 to 1,643,000 (1,421,000-1,782,000) cases in 2010, an annual rate of increase of 3·1%. Global cervical cancer incidence increased from 378,000 (256,000-489,000) cases per year in 1980 to 454,000 (318,000-620,000) cases per year in 2010-a 0·6% annual rate of increase. Breast cancer killed 425,000 (359,000-453,000) women in 2010, of whom 68,000 (62,000-74,000) were aged 15-49 years in developing countries. Cervical cancer death rates have been decreasing but the disease still killed 200,000 (139,000-276,000) women in 2010, of whom 46,000 (33,000-64,000) were aged 15-49 years in developing countries. We recorded pronounced variation in the trend in breast cancer mortality across regions and countries.
INTERPRETATION: More policy attention is needed to strengthen established health-system responses to reduce breast and cervical cancer, especially in developing countries. FUNDING: Susan G Komen for the Cure and the Bill & Melinda Gates Foundation.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21924486     DOI: 10.1016/S0140-6736(11)61351-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  351 in total

1.  Single nucleotide polymorphisms in PDCD6 gene are associated with the development of cervical squamous cell carcinoma.

Authors:  Bin Zhou; Peng Bai; Hui Xue; Zhu Zhang; Shaoqing Shi; Kui Zhang; Yanyun Wang; Kana Wang; Yi Quan; Yaping Song; Lin Zhang
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

Review 2.  Evaluation of cross-cultural adaptation and measurement properties of breast cancer-specific quality-of-life questionnaires: a systematic review.

Authors:  Indiara Soares Oliveira; Lucíola da Cunha Menezes Costa; Felipe Ribeiro Cabral Fagundes; Cristina Maria Nunes Cabral
Journal:  Qual Life Res       Date:  2014-11-13       Impact factor: 4.147

3.  Cancer incidence in Nigeria: a report from population-based cancer registries.

Authors:  Elima Jedy-Agba; Maria Paula Curado; Olufemi Ogunbiyi; Emmanuel Oga; Toyin Fabowale; Festus Igbinoba; Gloria Osubor; Theresa Otu; Henry Kumai; Alice Koechlin; Patience Osinubi; Patrick Dakum; William Blattner; Clement A Adebamowo
Journal:  Cancer Epidemiol       Date:  2012-05-22       Impact factor: 2.984

4.  Cancer in Africa: AORTIC 8th International Cancer Conference 'Entering the 21st Century for Cancer Control in Africa' 30.11.-2.12.2011.

Authors:  G Braun; A Führer; E Breitenstein; W Tariku; O Abdelbaghi; S Hauptmann; S Bogale; E Kantelhardt
Journal:  Breast Care (Basel)       Date:  2012-04       Impact factor: 2.860

Review 5.  Racial and ethnic disparities in the impact of obesity on breast cancer risk and survival: a global perspective.

Authors:  Elisa V Bandera; Gertraud Maskarinec; Isabelle Romieu; Esther M John
Journal:  Adv Nutr       Date:  2015-11-13       Impact factor: 8.701

6.  Association between TCF7L2 polymorphisms and breast cancer susceptibility: a meta-analysis.

Authors:  Feng Wang; Lixin Jiang; Jianlin Li; Xiao Yu; Mingchuan Li; Guochang Wu; Zhenyu Yu; Kai Zhou; Haidi Chu; Huiyuan Zhai
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 7.  Steroid hormone receptors as prognostic markers in breast cancer.

Authors:  Maggie C Louie; Mary B Sevigny
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

8.  17β-hydroxysteroid dehydrogenase type Gene 1937 A > G Polymorphism as a Risk Factor for Cervical Cancer Progression in the Polish Population.

Authors:  Anna Lutkowska; Andrzej Roszak; Pawel P Jagodziński
Journal:  Pathol Oncol Res       Date:  2016-08-29       Impact factor: 3.201

Review 9.  Heightened susceptibility: A review of how pregnancy and chemical exposures influence maternal health.

Authors:  Julia Varshavsky; Anna Smith; Aolin Wang; Elizabeth Hom; Monika Izano; Hongtai Huang; Amy Padula; Tracey J Woodruff
Journal:  Reprod Toxicol       Date:  2019-05-02       Impact factor: 3.143

10.  Hypoxia promotes the proliferation of cervical carcinoma cells through stimulating the secretion of IL-8.

Authors:  Li-Bing Liu; Feng Xie; Kai-Kai Chang; Ming-Qing Li; Yu-Han Meng; Xiao-Hui Wang; Hui Li; Da-Jin Li; Jin-Jin Yu
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.